MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 938.6 Million EUR | 2.46% |
| 2022 | 916.11 Million EUR | 3.96% |
| 2021 | 881.23 Million EUR | -0.7% |
| 2020 | 887.46 Million EUR | -1.15% |
| 2019 | 897.75 Million EUR | 101.86% |
| 2018 | 444.73 Million EUR | 20.65% |
| 2017 | 368.62 Million EUR | 6.21% |
| 2016 | 347.06 Million EUR | 5.35% |
| 2015 | 329.42 Million EUR | 3.07% |
| 2014 | 319.61 Million EUR | 2.16% |
| 2013 | 312.86 Million EUR | -2.11% |
| 2012 | 319.59 Million EUR | -2.81% |
| 2011 | 328.82 Million EUR | -2.25% |
| 2010 | 336.4 Million EUR | 0.79% |
| 2009 | 333.77 Million EUR | -2.72% |
| 2008 | 343.1 Million EUR | 27.12% |
| 2007 | 269.91 Million EUR | 0.56% |
| 2006 | 268.39 Million EUR | -0.06% |
| 2005 | 268.57 Million EUR | -25.69% |
| 2004 | 361.42 Million EUR | -4.64% |
| 2003 | 379.01 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 889.61 Million EUR | -1.3% |
| 2024 Q1 | 901.31 Million EUR | -3.97% |
| 2023 Q2 | 905.96 Million EUR | -0.73% |
| 2023 Q1 | 912.64 Million EUR | -0.38% |
| 2023 Q3 | 911.97 Million EUR | 0.66% |
| 2023 Q4 | 938.6 Million EUR | 2.92% |
| 2023 FY | 938.6 Million EUR | 2.46% |
| 2022 Q2 | 848.57 Million EUR | -3.38% |
| 2022 Q4 | 916.11 Million EUR | 8.79% |
| 2022 FY | 916.11 Million EUR | 3.96% |
| 2022 Q3 | 842.09 Million EUR | -0.76% |
| 2022 Q1 | 878.24 Million EUR | -0.34% |
| 2021 Q1 | 886.44 Million EUR | -0.11% |
| 2021 Q4 | 881.23 Million EUR | -0.54% |
| 2021 Q2 | 878.26 Million EUR | -0.92% |
| 2021 Q3 | 886.04 Million EUR | 0.89% |
| 2021 FY | 881.23 Million EUR | -0.7% |
| 2020 Q3 | 911.73 Million EUR | 1.02% |
| 2020 Q2 | 902.56 Million EUR | 1.07% |
| 2020 FY | 887.46 Million EUR | -1.15% |
| 2020 Q1 | 893 Million EUR | -0.53% |
| 2020 Q4 | 887.46 Million EUR | -2.66% |
| 2019 Q3 | 886.56 Million EUR | 0.16% |
| 2019 Q2 | 885.15 Million EUR | -0.63% |
| 2019 Q1 | 890.78 Million EUR | 100.3% |
| 2019 FY | 897.75 Million EUR | 101.86% |
| 2019 Q4 | 897.75 Million EUR | 1.26% |
| 2018 Q1 | 420.17 Million EUR | 13.98% |
| 2018 FY | 444.73 Million EUR | 20.65% |
| 2018 Q4 | 444.73 Million EUR | 2.35% |
| 2018 Q3 | 434.53 Million EUR | 4.1% |
| 2018 Q2 | 417.41 Million EUR | -0.66% |
| 2017 Q2 | 349.22 Million EUR | -0.15% |
| 2017 Q3 | 363.32 Million EUR | 4.04% |
| 2017 Q4 | 368.62 Million EUR | 1.46% |
| 2017 Q1 | 349.75 Million EUR | 0.78% |
| 2017 FY | 368.62 Million EUR | 6.21% |
| 2016 Q2 | 337.56 Million EUR | -0.2% |
| 2016 FY | 347.06 Million EUR | 5.35% |
| 2016 Q3 | 351.87 Million EUR | 4.24% |
| 2016 Q1 | 338.25 Million EUR | 2.68% |
| 2016 Q4 | 347.06 Million EUR | -1.37% |
| 2015 Q4 | 329.42 Million EUR | -1.95% |
| 2015 Q3 | 335.97 Million EUR | 3.12% |
| 2015 Q1 | 327.51 Million EUR | 2.47% |
| 2015 Q2 | 325.81 Million EUR | -0.52% |
| 2015 FY | 329.42 Million EUR | 3.07% |
| 2014 Q2 | 316.83 Million EUR | 0.51% |
| 2014 Q3 | 323.86 Million EUR | 2.22% |
| 2014 Q1 | 315.23 Million EUR | 0.76% |
| 2014 Q4 | 319.61 Million EUR | -1.31% |
| 2014 FY | 319.61 Million EUR | 2.16% |
| 2013 Q4 | 312.86 Million EUR | -0.36% |
| 2013 Q2 | 311.87 Million EUR | -0.32% |
| 2013 Q1 | 312.88 Million EUR | -2.1% |
| 2013 FY | 312.86 Million EUR | -2.11% |
| 2013 Q3 | 313.98 Million EUR | 0.68% |
| 2012 FY | 319.59 Million EUR | -2.81% |
| 2012 Q3 | 323.61 Million EUR | 1.08% |
| 2012 Q1 | 321.51 Million EUR | -2.22% |
| 2012 Q4 | 319.59 Million EUR | -1.24% |
| 2012 Q2 | 320.13 Million EUR | -0.43% |
| 2011 Q1 | 335.72 Million EUR | -0.2% |
| 2011 Q2 | 326.58 Million EUR | -2.72% |
| 2011 Q3 | 339.81 Million EUR | 4.05% |
| 2011 Q4 | 328.82 Million EUR | -3.23% |
| 2011 FY | 328.82 Million EUR | -2.25% |
| 2010 Q3 | 336.57 Million EUR | 1.34% |
| 2010 Q4 | 336.4 Million EUR | -0.05% |
| 2010 Q2 | 332.1 Million EUR | -0.27% |
| 2010 Q1 | 333 Million EUR | -0.23% |
| 2010 FY | 336.4 Million EUR | 0.79% |
| 2009 Q4 | 333.77 Million EUR | 0.0% |
| 2009 FY | 333.77 Million EUR | -2.72% |
| 2008 FY | 343.1 Million EUR | 27.12% |
| 2007 FY | 269.91 Million EUR | 0.56% |
| 2006 FY | 268.39 Million EUR | -0.06% |
| 2005 FY | 268.57 Million EUR | -25.69% |
| 2004 FY | 361.42 Million EUR | -4.64% |
| 2003 FY | 379.01 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 33.92 Billion EUR | 97.234% |
| Fresenius SE & Co. KGaA | 45.28 Billion EUR | 97.927% |
| LIMES Schlosskliniken AG | 33.24 Million EUR | -2723.028% |
| M1 Kliniken AG | 212.95 Million EUR | -340.759% |
| Maternus-Kliniken Aktiengesellschaft | 154.37 Million EUR | -507.99% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.77 Billion EUR | 47.249% |
| VITA 34 AG | 158.35 Million EUR | -492.717% |